HEOR
Charlotte Fleming, MSc, is a consultant specializing in Value & Access at HEOR since April 2024. Previously, Charlotte served as a Senior Analyst in SLR and NMA within Global Consulting Services at Clarivate from March 2021 to April 2024. Additional experience includes a role as an evidence summary writer at Evidence Aid and systematic review analyst positions at DRG/Clarivate and Mtech Access. Early career experience includes an internship as a Respiratory Laboratory Scientist at the Liverpool School of Tropical Medicine. Charlotte holds multiple degrees, including an MSc in Clinical Immunology from The University of Manchester, a degree in Biological and Biomedical Sciences from the University of Liverpool, and a recent MSc in International Health Technology Assessment and Reimbursement from The University of Sheffield. Currently, Charlotte is pursuing a part-time MSc in International HTA and Reimbursement at The University of Sheffield.
This person is not in any teams
HEOR
Established in 2011, HEOR is a leading independent market access consultancy with a reputation for high-quality, innovative market access strategies, evidence generation and value communications. We are a team of over 90 consulting and research professionals based in the UK and Germany and our expertise spans market access strategy, health economics, health technology assessments, pricing and reimbursement, data science and analytics, systematic literature reviews, evidence generation, medical writing, stakeholder engagement and value communication. We have a global presence and work across the UK, Europe, US, Canada, Asia-Pacific and the Middle East to provide a fully integrated market access service across the product life-cycle. HEOR Ltd acts as a trusted partner to the world’s major pharmaceutical and biopharmaceutical companies. Our clients value our flexibility, integrity to scientific principles and best practice and our ethos of true partnership, where our track record speaks to deep and continuing client collaborations, across all disease areas and service offerings.